BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT

Title

Virtual screening of ABCC1 transporter nucleotide-binding domains as a therapeutic target in multidrug resistant cancer

 

Authors

Kanin Rungsardthong, Sergio Mares- Sámano & Jeffrey Penny*

 

Affiliation

University of Manchester, School of Pharmacy & Pharmaceutical Sciences, Stopford Building, M13 9PT, UK.

 

Email

Jeffrey.penny@manchester.ac.uk; *Corresponding author

 

Article Type

Hypothesis

 

Date

Received September 19, 2012; Accepted September 20, 2012; Published October 01, 2012

 

Abstract

ABCC1, a member of the ATP-binding Cassette superfamily of transporters, actively effluxes xenobiotics from cells. Clinically, ABCC1 expression is linked to cancer multidrug resistance. Substrate efflux is energised by ATP binding and hydrolysis at the nucleotide-binding domains (NBDs) and inhibition of these events may help combat drug resistance. The aim of this study is to identify potential inhibitors of ABCC1 through virtual screening of National Cancer Institute (NCI) compounds. A three-dimensional model of ABCC1 NBD2 was generated using MODELLER whilst the X-ray crystal structure of ABCC1 NBD1 was retrieved from the Protein Data Bank. A pharmacophore hypothesis was generated based on flavonoids known to bind at the NBDs using PHASE, and used to screen the NCI database. GLIDE was employed in molecular docking studies for all hit compounds identified by pharmacophore screening. The best potential inhibitors were identified as compounds possessing predicted binding affinities greater than ATP. Approximately 5% (13/265) of the hit compounds possessed lower docking scores than ATP in ABCC1 NBD1 (NSC93033, NSC662377, NSC319661, NSC333748, NSC683893, NSC226639, NSC94231, NSC55979, NSC169121, NSC166574, NSC73380, NSC127738, NSC115534), whereas approximately 7% (7/104) of docked NCI compounds were predicted to possess lower docking scores than ATP in ABCC1 NBD2 (NSC91789, NSC529483, NSC211168, NSC318214, NSC116519, NSC372332, NSC526974). Analyses of docking orientations revealed P-loop residues of each NBD and the aromatic amino acids Trp653 (NBD1) and Tyr1302 (NBD2) were key in interacting with high-affinity compounds. On the basis of docked orientation and docking score the compounds identified may be potential inhibitors of ABCC1 and require further pharmacological analysis.

 

Keywords

Homology, ABCC1, Flavonoid, Pharmacophore, Docking, Nucleotide-binding domain

 

Abbreviation

ABC: ATP-binding cassette, DHS: dehydrosilybin, MDR: multidrug resistance, NBD: nucleotide-binding domain, PDB: protein data bank

 

Citation

Rungsardthong et al. Bioinformation 8(19): 907-911 (2012)
 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.